Human Insulin Market Size to Surpass USD 21.04 Billion by 2030, exhibiting a CAGR of 1.5%

As per the report by Fortune Business Insights, the global Human Insulin Market size is projected to reach USD 21.04 billion by 2030, at a CAGR of 1.5% during the forecast period.


Pune, India, May 04, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, global Human Insulin Market size was valued at USD 18.73 billion in 2022 and is projected to grow from USD 18.95 billion in 2023 to USD 21.04 billion by 2030, exhibiting a CAGR of 1.5% during the forecast period.

The increasing prevalence of diabetes and insulin analogues adoption to foster market growth. Fortune Business Insights™ presents this information in its report titled Human Insulin Market, 2023-2030.

Key Industry Development:

May 2020 - Novo Nordisk A/S announced its novel social responsibility ‘Defeat Diabetes’ program to expand the company’s Changing Diabetes in Children (CDiC) program.

Request a Free Sample PDF:

Key Takeaways

  • The growth of the human insulin market will be driven by the increasing prevalence of diabetes worldwide.
  • The human insulin market is expected to grow due to the increasing expenditure on healthcare devices.
  • Analogue insulin is expected to lead the human insulin market during the forecast period.
  • Human Insulin Market Size in North America was USD 8.63 billion in 2022.

"Discover the Leading Players Featured in the Report: Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi (France), BIOTON S.A. (Poland), Gan & Lee Pharmaceuticals (China), Biocon (India), Tonghua Dongbao Pharmaceutical (China), Julphar (UAE), Wockhardt (India)"

Report Scope & Segmentation

Report Coverage Details
Forecast Period 2023 to 2030
Forecast Period 2023 to 2030 CAGR 1.5%
2030 Value Projection USD 21.04 Billion
Base Year 2022
Human Insulin Market Size in 2022 USD 18.73 Billion
Historical Data for 2019 to 2021
No. of Pages 174
Segments covered Type, Diabetes Type, Distribution Channel and Geography
Human Insulin Market Growth Drivers Increasing prevalence of diabetes worldwide will drive the growth of the human insulin market.

Browse Complete Report Details:

Drivers and Restraints:

Novel Product Launches Facilitated the Market’s Growth

Human insulin is a hormone that regulates the body’s blood sugar levels. Insulin is used to treat patients who have diabetes. The rising prevalence of diabetes conditions is expected to enhance the demand for human insulin. Furthermore, the increasing launch of novel product manufacturers is expected to enhance the industry’s growth prospects. For example, Eli Lilly and Company received approval for their Mounjaro injection in May 2022. This injection helps type 2 patients advance their glycemic control. In addition, the increasing spending on healthcare devices is expected to drive the human insulin market growth.

However, the low diagnosis rate and lack of reimbursement policies may hamper the industry’s growth.

Segments Overview:

By Type

  • Analogue Insulin
    • Long-acting
    • Fast-acting
    • Premix
  • Traditional Human Insulin
    • Long-acting
    • Short-acting
    • Fast-acting
    • Premix

By Diabetes Type

  • Diabetes Type 1
  • Diabetes Type 2

By Distribution Channel

  • Hospital Pharmacies
  • Retail & Online Pharmacies

By Region

  • North America
  • Europe
  • Asia Pacific

Quick Buy - Human Insulin Market Research Report:

Competitive Landscape:

Companies Deploy Acquisition Strategies to Expand its Resources

The prominent companies operating in the market announce acquisition strategies to expand their resources. For example, Novo Nordisk A/S completed the acquisition of Dicerna Pharmaceuticals and Dicerna’s ribonucleic acid interference (RNAi) platform in November 2021. This strategy may allow Novo Nordisk A/S to boost its market reach. Furthermore, major companies deploy mergers, acquisitions, product launches, innovations, expansions, and research and development to boost their market position.


What is the size of Human Insulin Market?

Human Insulin Market size was USD 18.73 billion in 2022.

How fast is the Human Insulin Market growing?

The Human Insulin Market will exhibit a CAGR of 1.5% during the forecast period, 2023-2030

Related Reports:

Insulin Pump Market Share, Size, Trends and Forecast 2023-2030

Diabetes Drugs Market Size, Share, Trends, Growth | Global Forecast Report 2029

Diabetes Treatment Devices Market Size, Share, Trends, Growth 2023-2030

Diabetes Devices Market Analysis, Global Size and Industry Share Forecast 2023-2030

Blood Glucose Monitoring System Market Size, Share, Opportunities & Analysis 2023-2030

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245